Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
3.790
-0.110 (-2.82%)
Apr 29, 2026, 11:01 AM EDT - Market open
Orchestra BioMed Holdings Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | 34.69 | 22.26 | 30.56 | 19.78 | 9.94 | Upgrade
|
| Short-Term Investments | 71.82 | 44.55 | 57.04 | 64 | 0.96 | Upgrade
|
| Cash & Short-Term Investments | 106.51 | 66.81 | 87.6 | 83.79 | 10.9 | Upgrade
|
| Cash Growth | 59.42% | -23.73% | 4.55% | 668.95% | -69.56% | Upgrade
|
| Receivables | 0.1 | 0.09 | 0.1 | 0.1 | 0.12 | Upgrade
|
| Inventory | 0.31 | 0.17 | 0.15 | 0.28 | 0.07 | Upgrade
|
| Prepaid Expenses | 0.99 | 2.09 | 1.27 | 0.53 | 0.23 | Upgrade
|
| Total Current Assets | 107.91 | 69.17 | 89.11 | 84.69 | 11.32 | Upgrade
|
| Property, Plant & Equipment | 3.21 | 3.49 | 2.83 | 3.68 | 1.12 | Upgrade
|
| Long-Term Investments | 2.5 | 2.5 | 2.5 | 2.5 | 0.4 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 4 | 0.1 | Upgrade
|
| Other Long-Term Assets | 1.24 | 1.02 | 0.77 | 0.71 | 0.59 | Upgrade
|
| Total Assets | 114.86 | 76.17 | 95.21 | 95.57 | 13.53 | Upgrade
|
| Accounts Payable | 6.1 | 5.13 | 2.9 | 3.97 | 2.03 | Upgrade
|
| Accrued Expenses | 9.89 | 6.08 | 5.15 | 5.38 | 1.89 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 2 | Upgrade
|
| Current Portion of Leases | 0.75 | 0.55 | 0.65 | 0.7 | - | Upgrade
|
| Current Unearned Revenue | - | 4.44 | 2.51 | 6.44 | 5.54 | Upgrade
|
| Other Current Liabilities | - | - | - | 2.09 | 0.78 | Upgrade
|
| Total Current Liabilities | 16.74 | 16.21 | 11.21 | 18.57 | 12.24 | Upgrade
|
| Long-Term Debt | 14.27 | 14.29 | - | 9.49 | 3.67 | Upgrade
|
| Long-Term Leases | 0.94 | 1.69 | 1.04 | 1.68 | - | Upgrade
|
| Long-Term Unearned Revenue | - | 10.99 | 14.92 | 13.1 | 16.86 | Upgrade
|
| Other Long-Term Liabilities | 19.54 | 0.04 | - | 0.2 | 0.54 | Upgrade
|
| Total Liabilities | 51.48 | 43.22 | 27.17 | 43.04 | 33.31 | Upgrade
|
| Common Stock | 0.01 | 0 | 0 | 0 | - | Upgrade
|
| Additional Paid-In Capital | 416.08 | 342.78 | 316.9 | 252.27 | 94.89 | Upgrade
|
| Retained Earnings | -362.58 | -309.88 | -248.85 | -199.73 | -166.13 | Upgrade
|
| Comprehensive Income & Other | 0.06 | 0.05 | -0.01 | -0.01 | - | Upgrade
|
| Total Common Equity | 53.57 | 32.96 | 68.04 | 52.53 | -71.23 | Upgrade
|
| Shareholders' Equity | 63.38 | 32.96 | 68.04 | 52.53 | -19.78 | Upgrade
|
| Total Liabilities & Equity | 114.86 | 76.17 | 95.21 | 95.57 | 13.53 | Upgrade
|
| Total Debt | 15.96 | 16.53 | 1.69 | 11.87 | 5.67 | Upgrade
|
| Net Cash (Debt) | 90.56 | 50.28 | 85.91 | 71.92 | 5.22 | Upgrade
|
| Net Cash Growth | 80.09% | -41.47% | 19.46% | 1276.89% | -80.17% | Upgrade
|
| Net Cash Per Share | 1.90 | 1.37 | 2.59 | 4.80 | 2.47 | Upgrade
|
| Filing Date Shares Outstanding | 58.52 | 38.31 | 35.78 | 2.52 | 2.19 | Upgrade
|
| Total Common Shares Outstanding | 57.03 | 38.19 | 35.78 | 2.52 | 2.19 | Upgrade
|
| Working Capital | 91.18 | 52.96 | 77.91 | 66.12 | -0.92 | Upgrade
|
| Book Value Per Share | 0.94 | 0.86 | 1.90 | 20.83 | -32.60 | Upgrade
|
| Tangible Book Value | 53.57 | 32.96 | 68.04 | 52.53 | -71.23 | Upgrade
|
| Tangible Book Value Per Share | 0.94 | 0.86 | 1.90 | 20.83 | -32.60 | Upgrade
|
| Machinery | 3.19 | 2.53 | 2.12 | 2.08 | 1.51 | Upgrade
|
| Construction In Progress | - | - | - | - | 0.02 | Upgrade
|
| Leasehold Improvements | 0.16 | 0.16 | 0.2 | 0.19 | 0.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.